These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1010 related articles for article (PubMed ID: 17986161)

  • 1. Improved cancer pain treatment using combined fentanyl-TTS and tramadol.
    Marinangeli F; Ciccozzi A; Aloisio L; Colangeli A; Paladini A; Bajocco C; Coaccioli S; Varrassi G
    Pain Pract; 2007 Dec; 7(4):307-12. PubMed ID: 17986161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. From codeine to transdermal fentanyl for cancer pain control: a safety and efficacy clinical trial.
    Mystakidou K; Befon S; Kouskouni E; Gerolymatos K; Georgaki S; Tsilika E; Vlahos L
    Anticancer Res; 2001; 21(3C):2225-30. PubMed ID: 11501851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of TTS-fentanyl with sustained-release oral morphine in the treatment of patients not using opioids for mild-to-moderate pain.
    van Seventer R; Smit JM; Schipper RM; Wicks MA; Zuurmond WW
    Curr Med Res Opin; 2003; 19(6):457-69. PubMed ID: 14594516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Phase III study to assess the clinical utility of low-dose fentanyl transdermal system in patients with chronic nonmalignant pain.
    Otis J; Rothman M
    Curr Med Res Opin; 2006 Aug; 22(8):1493-501. PubMed ID: 16870074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transdermal buprenorphine patches applied in a 4-day regimen versus a 3-day regimen: a single-site, Phase III, randomized, open-label, crossover comparison.
    Likar R; Lorenz V; Korak-Leiter M; Kager I; Sittl R
    Clin Ther; 2007 Aug; 29(8):1591-606. PubMed ID: 17919542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management.
    Mercadante S; Porzio G; Ferrera P; Fulfaro F; Aielli F; Verna L; Villari P; Ficorella C; Gebbia V; Riina S; Casuccio A; Mangione S
    Eur J Pain; 2008 Nov; 12(8):1040-6. PubMed ID: 18353696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of safety and efficacy of transdermal therapeutic system-fentanyl in adult patients with gynecological cancer-related pain.
    Lorvidhaya V; Katanyoo K; Srisomboon J; Suprapaphorn P; Cheewakriangkrai C
    J Med Assoc Thai; 2004 Mar; 87(3):319-25. PubMed ID: 15117050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in the prescribed daily doses of transdermal fentanyl and transdermal buprenorphine during treatment of patients with cancer and noncancer pain in Germany: results of a retrospective cohort study.
    Sittl R; Nuijten M; Nautrup BP
    Clin Ther; 2005 Jul; 27(7):1022-31. PubMed ID: 16154481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of transdermal fentanyl in cancer pain--a compliance study of outpatients in Taiwan.
    Chiou TJ; Liu CY; Tzeng WF; Su YC; Weng YC; Hung CJ; Tang Y; Chen YJ;
    Am J Hosp Palliat Care; 2010 Feb; 27(1):31-7. PubMed ID: 19801533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of transdermal fentanyl patch for treatment of acute pain due to oral mucositis in patients receiving stem cell transplantation.
    Kim JG; Sohn SK; Kim DH; Baek JH; Chae YS; Bae NY; Kim SY; Lee KB
    Transplant Proc; 2005 Dec; 37(10):4488-91. PubMed ID: 16387151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and tolerability of intranasal fentanyl spray 50 to 200 microg for breakthrough pain in patients with cancer: a phase III, multinational, randomized, double-blind, placebo-controlled, crossover trial with a 10-month, open-label extension treatment period.
    Kress HG; Orońska A; Kaczmarek Z; Kaasa S; Colberg T; Nolte T
    Clin Ther; 2009 Jun; 31(6):1177-91. PubMed ID: 19695386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of transdermal fentanyl without prior opioid stabilization in patients with cancer pain.
    Tawfik MO; Bryuzgin V; Kourteva G;
    Curr Med Res Opin; 2004 Mar; 20(3):259-67. PubMed ID: 15025835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utilisation pattern of fentanyl transdermal system in The Netherlands.
    Breekveldt-Postma NS; Penning-van Beest FJ; Herings RM
    Pharmacoepidemiol Drug Saf; 2005 Feb; 14(2):129-34. PubMed ID: 15386723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transdermal fentanyl in HSCT patients: an open trial using transdermal fentanyl for the treatment of oral mucositis pain.
    Demarosi F; Lodi G; Soligo D; Sardella A; Volpe AD; Carrassi A; Deliliers GL
    Bone Marrow Transplant; 2004 Jun; 33(12):1247-51. PubMed ID: 15094750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of transdermal fentanyl and sustained-release oral morphine in patients with cancer and chronic non-cancer pain.
    Clark AJ; Ahmedzai SH; Allan LG; Camacho F; Horbay GL; Richarz U; Simpson K
    Curr Med Res Opin; 2004 Sep; 20(9):1419-28. PubMed ID: 15383190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized, open, parallel group, multicenter trial to investigate analgesic efficacy and safety of a new transdermal fentanyl patch compared to standard opioid treatment in cancer pain.
    Kress HG; Von der Laage D; Hoerauf KH; Nolte T; Heiskanen T; Petersen R; Lundorff L; Sabatowski R; Krenn H; Rosland JH; Saedder EA; Jensen NH
    J Pain Symptom Manage; 2008 Sep; 36(3):268-79. PubMed ID: 18538974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiotherapy plus either transdermal fentanyl or paracetamol and codeine for painful bone metastases: a randomised study of pain relief and quality of life.
    Pistevou-Gompaki K; Kouloulias VE; Varveris C; Mystakidou K; Georgakopoulos G; Eleftheriadis N; Gompakis N; Kouvaris J
    Curr Med Res Opin; 2004; 20(2):159-63. PubMed ID: 15006009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inter- and intra-individual variability in transdermal fentanyl absorption in cancer pain patients.
    Solassol I; Caumette L; Bressolle F; Garcia F; Thézenas S; Astre C; Culine S; Coulouma R; Pinguet F
    Oncol Rep; 2005 Oct; 14(4):1029-36. PubMed ID: 16142368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Equipotent doses of transdermal fentanyl and transdermal buprenorphine in patients with cancer and noncancer pain: results of a retrospective cohort study.
    Sittl R; Likar R; Nautrup BP
    Clin Ther; 2005 Feb; 27(2):225-37. PubMed ID: 15811486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transdermal fentanyl in cancer patients with moderate-to-severe pain: a prospective examination.
    Iconomou G; Viha A; Vagenakis AG; Kalofonos HP
    Anticancer Res; 2000; 20(6C):4821-4. PubMed ID: 11205226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 51.